The net result of these mechanisms is a self-perpetuating cycle in which obesity-driven inflammation and insulin resistance accelerate muscle catabolism, and low muscle mass in turn worsens metabolic dysfunction—an unhealthy synergy that has been termed “sarcopenic obesity.” The gene discussed is INS; the disease is obesity disorder.